Last update 11 Oct 2025

RSS0393

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
RSS0393
Target-
Action-
Mechanism-
Therapeutic Areas
Immune System DiseasesSkin and Musculoskeletal DiseasesCongenital Disorders
Active Indication
Mild Atopic DermatitisModerate Atopic DermatitisChronic large plaque psoriasis+ [1]
Inactive Indication-
Originator Organization
Reistone Biopharma Co. Ltd.Reistone Biopharma Co. Ltd.
Active Organization
Reistone Biopharma Co. Ltd.Reistone Biopharma Co. Ltd.
Jiangsu Hengrui Pharmaceuticals Co., Ltd.Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with RSS0393
NCT07158151
/ RecruitingPhase 2
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study Evaluating the Efficacy and Safety of RSS0393 Ointment in Adults With Mild to Moderate Atopic Dermatitis
NCT07102888
/ Not yet recruitingPhase 2
A Phase II Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adolescents With Plaque Psoriasis
NCT06918743
/ Not yet recruitingPhase 2
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study Evaluating the Efficacy and Safety of RSS0393 Ointment Local Administration in Adults With Chronic Plaque Psoriasis
100 Clinical Results associated with RSS0393
Login to view more data
100 Translational Medicine associated with RSS0393
Login to view more data
100 Patents (Medical) associated with RSS0393
Login to view more data
100 Deals associated with RSS0393
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Mild Atopic DermatitisPhase 2
China
Reistone Biopharma Co. Ltd.Reistone Biopharma Co. Ltd.
17 Sep 2025
Moderate Atopic DermatitisPhase 2
China
Reistone Biopharma Co. Ltd.Reistone Biopharma Co. Ltd.
17 Sep 2025
Chronic large plaque psoriasisPhase 2-
Jiangsu Hengrui Pharmaceuticals Co., Ltd.Jiangsu Hengrui Pharmaceuticals Co., Ltd.
01 Apr 2025
Plaque psoriasisPhase 2
China
Reistone Biopharma Co. Ltd.Reistone Biopharma Co. Ltd.
27 Mar 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free